Generate a tailored SOP for Dr. Reuben Benjamin. Improve your application with a focused, well-structured draft.
Reuben Benjamin is a Clinical Senior Lecturer at King's College London with a focus on hematology, particularly in the context of chimeric antigen receptor T cells (CAR T) therapy for hematological malignancies. He leads the Cellular Immunotherapy Group, dedicated to developing and optimizing allogeneic 'off-the-shelf' CAR T cells and deciphering the mechanisms of resistance in blood cancers. His clinical research interests include multiple myeloma, where he studies the pathogenesis of extramedullary myeloma and works on flow cytometry methods for monitoring the disease. Reuben has contributed significantly to understanding tumor-activated lymph node fibroblasts and their role in suppressing T cell function in conditions such as diffuse large B cell lymphoma. He is involved in various research outputs examining the impact of COVID-19 on cancer patients and has published his findings in several peer-reviewed journals.
Requirements are consistent across King's Business School and Social Science & Public Policy departments for standard Master's entries.